Stenkrona, Per <br/><br/>
5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.  [electronic resource] 

 -  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology  Oct 2013 
 - 1190-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7862 
<br/><br/><label>Standard No.: </label>10.1016/j.euroneuro.2013.01.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Benzylamines--metabolism<br/>Carbon Radioisotopes<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Ligands<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Nerve Tissue Proteins--agonists<br/>Neurons--diagnostic imaging<br/>Piperazines--administration & dosage<br/>Positron-Emission Tomography<br/>Pyridines--metabolism<br/>Radiopharmaceuticals--metabolism<br/>Raphe Nuclei--diagnostic imaging<br/>Receptor, Serotonin, 5-HT1A--chemistry<br/>Serotonin 5-HT1 Receptor Agonists--administration & dosage<br/>Serotonin Plasma Membrane Transport Proteins--agonists<br/>Selective Serotonin Reuptake Inhibitors--administration & dosage<br/>Sulfides--administration & dosage<br/>Tissue Distribution<br/>Vortioxetine<br/>Young Adult